Ayuto Kodama | Medicine and Health Sciences | Innovative Research Award

Published on by Computer Scientists Awards

Innovative Research Award

Ayuto Kodama
Akita University, Japan

Ayuto Kodama
Affiliation Akita University
Country Japan
Scopus ID 57190225780
Documents 26
Citations 193
h-index 8
Subject Area Medicine and Health Sciences
Event Computer Scientists Awards
ORCID 0000-0002-2583-9422

Ayuto Kodama is a researcher affiliated with Akita University, Japan, whose documented research activity is situated within medicine and health sciences. The available publication record includes studies addressing driving risk assessment, mild cognitive impairment, mobility measurement, and frailty prevention among older adults. These topics connect clinical research with practical approaches to aging, safety, functional assessment, and community health. [1]

Abstract

Ayuto Kodama’s research profile encompasses empirical work on health and safety among older adults. Recent publications examine driving-risk assessment, walking-speed measurement, mild cognitive impairment, and exercise-based approaches to frailty prevention. The studies demonstrate an applied research orientation in which measurable clinical or behavioral indicators are examined for their potential relevance to assessment and prevention. [2]

Keywords

  • Geriatric health, mild cognitive impairment, driving risk, walking speed, frailty, older adults, clinical assessment

Introduction

Research concerning healthy aging increasingly incorporates multidimensional assessment of physical function, cognition, mobility, and safety. Kodama’s listed publications address several of these dimensions, including the measurement of daily walking speed using smartphones and the assessment of driving-related risks in community-dwelling older adults. [3]

Research Profile

The supplied bibliographic profile records 26 documents, 193 citations, and an h-index of 8 under Scopus ID 57190225780. The research is associated with Akita University and the subject area of Medicine and Health Sciences. ORCID identifier 0000-0002-2583-9422 provides an additional persistent researcher identifier.

Research Contributions

The publication record covers methodological and clinically oriented questions. One study evaluates the structure of the Driving Risk Checklist-25 through exploratory factor analysis and parallel analysis, while another investigates smartphone-based walking-speed measurement and its predictive utility for mild cognitive impairment. [1] Additional work examines driving-risk characteristics and a pole-assisted multicomponent exercise intervention for frailty prevention. [4]

Publications

  • Exploratory Factor Analysis of the Driving Risk Checklist-25 Among Community-Dwelling Older Adults — Safety, 2026.
  • Time-stratified daily walking speed measurement via smartphone and its predictive utility for mild cognitive impairment — Scientific Reports, 2026.
  • Characteristics of Driving Risk Checklist-25 among community-dwelling older adults with mild cognitive impairment — Geriatrics & Gerontology International, 2025.
  • Effects of Pole-Assisted Multicomponent Exercise on Preventing Frailty Among Older Adults in Japan — Psychogeriatrics, 2025.

Research Impact

The documented citation count and publication portfolio indicate that Kodama’s work has received scholarly attention. The subject matter also has practical relevance to geriatric assessment and community-based health research, particularly where objective measures may support evaluation of cognition, mobility, driving safety, or frailty. These observations are descriptive and do not independently establish clinical effectiveness.

Award Suitability

For an Innovative Research Award consideration, the documented record provides several areas for review, including methodological development in driving-risk assessment, technology-assisted mobility measurement, and intervention research involving older adults. The final assessment of suitability should be based on the award’s published criteria, verified bibliographic records, and the relevant evaluation process of Computer Scientists Awards.

Conclusion

Ayuto Kodama’s documented research profile reflects sustained activity in medicine and health sciences, with particular attention to aging, cognition, mobility, driving safety, and frailty. The combination of quantitative assessment and applied health research provides a substantive basis for academic recognition review within the stated award category.

References

  1. Elsevier. (n.d.). Scopus author details: Ayuto Kodama, Author ID 57190225780. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57190225780
  2. Kodama, A. (2026). Exploratory Factor Analysis of the Driving Risk Checklist-25 Among Community-Dwelling Older Adults. Safety.
    https://doi.org/10.3390/safety12050119
  3. Kodama, A. (2026). Time-stratified daily walking speed measurement via smartphone and its predictive utility for mild cognitive impairment. Scientific Reports.
    https://researchmap.jp/a-kodama/published_papers/53962882
  4. Kodama, A. (2025). Characteristics of Driving Risk Checklist-25 among community-dwelling older adults with mild cognitive impairment. Geriatrics & Gerontology International.
    https://doi.org/10.1111/ggi.70127
  5. Kodama, A. (2025). Effects of Pole-Assisted Multicomponent Exercise on Preventing Frailty Among Older Adults in Japan: A Quasi-Experimental Study. Psychogeriatrics.
    https://doi.org/10.1111/psyg.70067
  6. ORCID. (n.d.). Ayuto Kodama ORCID record.
    https://orcid.org/0000-0002-2583-9422
  7. Computer Scientists Awards. (n.d.). Official Award Website.
    https://computerscientists.net/

Dr. Lova Kajuluri | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Lova Kajuluri | Medicine | Best Researcher Award

Postdoctoral Research Fellow, Mass General Brigham, United States

Lova Prasadareddy Kajuluri is a Postdoctoral Research Fellow at the Cardiovascular Research Center, Massachusetts General Hospital (MGH), Charlestown, USA. He is recognized for his significant contributions to cardiovascular research, particularly in understanding vascular calcification and its potential treatments. With a strong background in biotechnology, Kajuluri has advanced in his research career through various prestigious roles in both India and the United States. He holds a Doctorate in Science from the CSIR-Central Drug Research Institute, Lucknow, India, and has received multiple research grants to further his studies in cardiovascular diseases. 🚀

Publication Profile

Education Background

Kajuluri’s educational journey began with a Bachelor of Science in Biotechnology, Biochemistry, and Chemistry from Andhra University in 2007. He continued to pursue a Master of Science in Biotechnology from Andhra University, followed by a Ph.D. in Science from CSIR-Central Drug Research Institute, India. His academic excellence has paved the way for several postdoctoral positions, starting from his research fellowship at Boston University to his current position at Massachusetts General Hospital, where he continues to explore novel therapies in cardiovascular research. 🎓📚

Professional Experience

Kajuluri’s professional career began as a Research Fellow at CSIR-Central Drug Research Institute in India, focusing on Leishmaniasis and actin-related proteins. He transitioned to postdoctoral research at Boston University, where he led studies on vascular smooth muscle contraction and calponin. His current role as a Postdoctoral Research Fellow at MGH involves leading studies on vascular calcification, gene therapy, and identifying therapeutic targets to treat cardiovascular diseases. His extensive research in these areas contributes significantly to the advancement of vascular health. 🔬🧑‍🔬

Awards and Honors

Kajuluri has received numerous prestigious awards throughout his career. Notably, he was awarded the Research Fellowship from the University Grants Commission, New Delhi, India (2011-2016). He has also been a part of several funded research projects, including those supported by the National Heart, Lung, and Blood Institute, USA. His dedication to advancing cardiovascular and infectious disease research has earned him recognition from the scientific community. 🏆🎖️

Research Focus

Kajuluri’s research is focused on understanding the molecular mechanisms underlying vascular calcification, a condition that contributes to cardiovascular diseases. His current studies explore gene therapies to treat vascular calcification in infants, as well as the role of histone deacetylases in vascular health. Additionally, his earlier work in Leishmaniasis has expanded his expertise to parasitology and cellular biology. His work bridges cardiovascular research and therapeutic innovation, offering potential treatments for critical vascular conditions. ❤️🧬

Conclusion

Lova Prasadareddy Kajuluri’s career is a testament to his commitment to advancing science in cardiovascular health and infectious diseases. Through his research, he continues to provide invaluable insights into vascular calcification and gene therapy, offering hope for future treatments in these fields. 🌟🔬

Publication Top Notes

Epigenetic Regulation of Human Vascular Calcification. Genes, 2025, 16, 506. DOI

Calponin 1 inhibits agonist-induced ERK activation and decreases calcium sensitization in vascular smooth muscle.  Journal of Cellular and Molecular Medicine, January 28, 2024. PubMed

Treatment of calcific arterial disease via enhancement of autophagy using GSK343.  iScience, October 28, 2023. PubMed

Intracellular localization of MyosinXXI discriminates Leishmania spp and Leptomonas seymouri.  Biochemical and Biophysical Research Communications, May 14, 2022. PubMed

Actin-related protein 4: An unconventional negative regulator of mitochondrial calcium in protozoan parasite Leishmania.  Mitochondrion, Jan 2022. PubMed

Vascular aging, the vascular cytoskeleton and aortic stiffness.  Exploration of Medicine, June 2021. PubMed

The uterine myocyte, contractile machinery and proteins of the myometrium and their relationship to the dynamic nature of myometrial function.  Current Opinion in Physiology, February 2020. ScienceDirect

A twinfilin-like protein coordinates karyokinesis by influencing mitotic spindle elongation and DNA replication in Leishmania.  Molecular Microbiology, April 2016. PubMed

Oligomerization of coronin: Implication on actin filament length in Leishmania. Cytoskeleton (Hoboken, N.J.), December 2015. PubMed

Sandhya Panch | Health Sciences | Women Researcher Award

Published on by Computer Scientists Awards

Dr. Sandhya Panch | Health Sciences | Women Researcher Award

Associate Professor, University of Washington, United States

Dr. Sandhya R. Panch, MD, MPH, is an esteemed Associate Professor of Medicine at the University of Washington and the Medical Director of Transfusion at the Fred Hutchinson Cancer Center. With a rich background in hematology and transfusion medicine, Dr. Panch has significantly contributed to both academic and clinical fields. Her extensive experience includes roles at the National Institutes of Health and various prestigious institutions, making her a leading expert in her specialty.

Profile

Strengths for the Award

  1. Extensive Research Contributions: Dr. Sandhya R. Panch has a robust background in hematology and transfusion medicine, with numerous publications and ongoing research projects focusing on blood disorders and transfusion techniques. Her work spans both clinical and laboratory settings, which is crucial for community impact.
  2. Leadership and Academic Roles: She holds significant positions, such as Associate Professor of Medicine at the University of Washington and Medical Director at the Fred Hutchinson Cancer Center, demonstrating her leadership and commitment to advancing medical knowledge and practice.
  3. Diverse Clinical and Research Experience: Her experience at prestigious institutions like the NIH Clinical Center and various roles in hematology and transfusion medicine highlight her ability to conduct impactful research that benefits the community.
  4. Grant and Funding Success: Dr. Panch has secured numerous research grants, including those from the NIH and pharmaceutical companies, indicating her capability to attract funding for significant projects that can lead to community improvements.
  5. Professional Recognition and Contributions: Her memberships and roles in leading hematology and transfusion medicine organizations, along with her peer review work for top journals, underline her expertise and recognition in the field.

Areas for Improvement

  1. Broader Community Engagement: While her research is highly specialized and impactful within the medical community, expanding outreach and direct engagement with broader community health initiatives could further demonstrate her commitment to community impact.
  2. Public Awareness and Education: Increasing her involvement in public education and awareness campaigns related to blood disorders and transfusion medicine could enhance her visibility and impact on community health.
  3. Interdisciplinary Collaboration: Encouraging more interdisciplinary research and collaboration with other fields, such as public health policy or social sciences, could broaden the scope and applicability of her research findings to address community health issues more comprehensively.

    Education 🎓📖

    Dr. Panch earned her MBBS from Bangalore Medical College and Research Institute in India. She furthered her education with a Master’s in Public Health (Epidemiology and Biostatistics) from the University of Minnesota. Her postdoctoral training includes a residency in Internal Medicine at Georgetown University Hospital, followed by a Clinical Fellowship in Transfusion Medicine at the National Institutes of Health, where she also completed a Post-doctoral Research Fellowship in Molecular Hematopoiesis under the mentorship of Dr. Cynthia E. Dunbar.

    Experience 🏥👩‍⚕️

    Dr. Panch has held numerous prestigious positions throughout her career. Currently, she serves as an Associate Professor at the University of Washington and Medical Director of Transfusion at Fred Hutchinson Cancer Center. Her previous roles include Assistant Research Physician at the NIH Clinical Center and Medical Director at the Center for Cellular Engineering. She has also served as an Attending Physician at NHLBI, NIH, and INOVA SCHAR Cancer Institute, contributing to both clinical practice and research.

    Research Interests 🔬🧬

    Dr. Panch’s research interests are deeply rooted in hematology and transfusion medicine. She focuses on improving hematopoietic progenitor cell mobilization, understanding the impact of manufacturing-related parameters on CAR T-cell product quality, and exploring the safety and efficacy of various treatments for hematologic conditions. Her work aims to enhance patient outcomes through innovative therapeutic approaches and clinical trials.

    Awards 🏆🎖️

    Dr. Panch has received numerous awards and grants throughout her career, including the National Blood Foundation Early Career Award and the NIH Clinical Center Research Award for Staff Clinicians Program. She has been recognized for her contributions to hematology and transfusion medicine, reflecting her dedication to advancing medical research and patient care.

    Publications 📚🖇️